STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns

France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns. research global health Physicians Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Pharmalot French regulator fines Novo and Lilly over weight loss ad campaigns The penalties reflect increasing concern among regulators…

Source: STAT News Pharma